In this article the authors review current evidence and guidance for the treatment of Chronic obstructive pulmonary disease (COPD) to bring up to date the Primary Care Respiratory Society (PCRS) consensus approach and algorithm first published in 2017 and then again in 2023 known as ‘Keeping it S

This document is a distillation of the new guidance to provide distinct advice on the changes on the diagnosis and management to asthma. It is not intended to be a comprehensive guide of the new guideline, neither does it cover all non-pharmacological treatments or on-going monitoring.

Inhalation is the main route for administration of drugs for conditions such as asthma or chronic obstructive pulmonary disease. The advantage of administering drugs by inhaler is that drugs are delivered directly to the site of action within the airways.

Knowing how to use Very Brief Advice to instigate a quit attempt and supporting smokers who are ready to quit is the business of every healthcare professional.Treating tobacco dependency systematically and effectively will have a significant impact on the triple aim:

Asthma Guidelines in Practice – A PCRS Consensus is a practical and pragmatic guide for healthcare professionals working in primary and intermediate care.  This guide was commissioned to provide clarity on aspects of diagnosis, management and monitoring of asthma that are uncertain

In this article Anthony Ball and Rachel Williams provide a summary of why it is so important to address poor housing as a way of tackling health inequalities.

Digital technology aims to improve access to healthcare. However, for certain individuals with respiratory conditions, it may introduce additional barriers rather than eliminating existing ones.

This article aims to support healthcare professionals working within general practice to implement Ten ways to implement sustainable greener healthcare in primary care respiratory practice, a publication from the Primary Care Respiratory Society (PCRS).

Are you passionate about respiratory care but frustrated by the pace of change? Do you have ideas about how things could be done better, but aren’t sure how to make your voice heard?

CARRii’s inaugural annual scientific meeting brought together over 100 researchers, clinicians, innovators and patient partners from across the UK at a critical moment for the health service.

The UK Inhaler Group (UKIG) has produced a practical concise guide to support healthcare professionals in selecting and using spacer and valved holding chamber (VHC) devices for patients with asthma and COPD.

Asthma is a long term condition caused by inflammation of the airways leading to wheeze, cough, breathlessness and chest tightness. It is the most common chronic condition in childhood, affecting around 1.1 million children in the UK, equivalent to three children in every classroom.

CARRii (Centre for Applied Respiratory Research & Innovation) is a UK research centre dedicated to enhancing lung health by supporting the implementation of high-quality research into clinical practice, with the aim of reducing hospital admissions, easing NHS winter healthcare pressures, and

Anaphylaxis is a time-critical emergency. Prompt intramuscular (IM) adrenaline remains the first-line treatment, rapidly reversing airway oedema, vasodilatation and bronchospasm (MHRA, 2023).

Healthcare professionals who are passionate about improving respiratory care are invited to attend the PCRS Respiratory Conference from 24th to 26th of September 2026 at the Telford International Centre.